Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Acer Therapeutics Inc. (ACER)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K10-K
Revenues   [+]0.011.91.31.30.00.00.00.0
            Revenue growth  -100.0%846.4%      
Cost of goods sold  0.024.60.017.20.00.00.00.0
Gross profit  0.0-12.71.3-15.90.00.00.00.0
            Gross margin   -106.4%100.0%-1265.7%    
Selling, general and administrative   [+]24.6 17.2 11.016.09.35.2
Research and development      11.813.912.58.7
Other operating expenses  3.211.9-1.1     
EBITDA   [+]    -22.7-29.8-21.7-13.9
            EBITDA margin   -206.4%-1174.6%-1265.7%    
Depreciation and amortization      0.10.10.00.0
EBIT   [+]-27.9-24.6-14.8-15.9-22.8-29.9-21.7-13.9
            EBIT margin   -206.4%-1174.6%-1265.7%    
Interest income        0.40.0
Other income (expense), net   [+]1.6-1.6-0.60.6-0.10.50.0-0.3
Pre-tax income  -26.2-26.2-15.4-15.4-22.9-29.4-21.3-14.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -26.2-26.2-15.4-15.4-22.9-29.4-21.3-14.2
            Net margin   -220.0%-1220.2%-1220.2%    
   
Basic EPS   [+]($1.66)($1.66)($1.08)($1.08)($2.06)($2.91)($2.49)($3.84)
Diluted EPS   [+]($1.66)($1.66)($1.08)($1.08)($2.06)($2.91)($2.49)($3.84)
   
Shares outstanding (basic)   [+]15.815.814.314.311.110.18.63.7
Shares outstanding (diluted)   [+]15.815.814.314.311.110.18.63.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy